Amazon tightened listing and Sponsored Ads requirements for supplement-adjacent categories in 2026 — and a delisting there can ripple into your other ad accounts.
Amazon's 2026 supplement policy update tightened listing and advertising requirements across the health and personal care categories, and peptide brands selling or advertising through Amazon are squarely inside the affected scope — even brands that treat Amazon as a secondary channel behind Google and Meta.
A delisting or account-health flag on Amazon doesn't stay contained to Amazon. Payment processors and, increasingly, Google's own merchant policy reviewers cross-reference marketplace account health as a trust signal — a documented Amazon delisting can make a Google Merchant Center review stricter even though the two platforms have no formal data-sharing relationship.
This is the same cross-platform compliance discipline that took a supplement brand from $8K to $148K/month without a single platform-level account loss.
Marketplace compliance is easy to deprioritize until it affects every other channel at once. Get a free strategy session with Oney Studio.
Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.
Book a Free Audit